141 related articles for article (PubMed ID: 22164745)
1. The efficacy of two different doses of vaginal isosorbide mononitrate in pre induction cervical ripening: a double blind randomised controlled trial.
Vidanagamage RS; Goonewardene IM
Ceylon Med J; 2011 Sep; 56(3):91-100. PubMed ID: 22164745
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide donor isosorbide mononitrate for pre-induction cervical ripening at 41 weeks' gestation: A randomized controlled trial.
Rameez MF; Goonewardene IM
J Obstet Gynaecol Res; 2007 Aug; 33(4):452-6. PubMed ID: 17688611
[TBL] [Abstract][Full Text] [Related]
3. Vaginal application of the nitric oxide donor isosorbide mononitrate for preinduction cervical ripening: a randomized controlled trial to determine effects on maternal and fetal hemodynamics.
Nicoll AE; Mackenzie F; Greer IA; Norman JE
Am J Obstet Gynecol; 2001 Apr; 184(5):958-64. PubMed ID: 11303205
[TBL] [Abstract][Full Text] [Related]
4. Evaluating the efficacy of outpatient use of isosorbide mononitrate on cervical ripening in pregnant women with unfavourable cervix.
Kashanian M; Jangjoo S; Sheikhansari N; KaramiAbd T
J Obstet Gynaecol; 2021 Aug; 41(6):876-880. PubMed ID: 33225782
[TBL] [Abstract][Full Text] [Related]
5. Outpatient vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening and labor induction postterm: a randomized controlled study.
Bullarbo M; Orrskog ME; Andersch B; Granström L; Norström A; Ekerhovd E
Am J Obstet Gynecol; 2007 Jan; 196(1):50.e1-5. PubMed ID: 17240231
[TBL] [Abstract][Full Text] [Related]
6. Intravaginal administration of isosorbide mononitrate for cervical ripening in prolonged pregnancy: a randomised clinical trial.
Mirteimouri M; Pourali L; Najaf Najafi M; Ghaffarian Omid M
J Obstet Gynaecol; 2020 Aug; 40(6):792-796. PubMed ID: 31852287
[TBL] [Abstract][Full Text] [Related]
7. Randomised placebo-controlled trial of outpatient (at home) cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour--clinical trial with analyses of efficacy and acceptability. The IMOP study.
Bollapragada SS; MacKenzie F; Norrie JD; Eddama O; Petrou S; Reid M; Norman JE
BJOG; 2009 Aug; 116(9):1185-95. PubMed ID: 19624440
[TBL] [Abstract][Full Text] [Related]
8. Vaginal administration of the nitric oxide donor isosorbide mononitrate for cervical ripening at term: a randomized controlled study.
Ekerhovd E; Bullarbo M; Andersch B; Norström A
Am J Obstet Gynecol; 2003 Dec; 189(6):1692-7. PubMed ID: 14710100
[TBL] [Abstract][Full Text] [Related]
9. Intracervical application of the nitric oxide donor isosorbide dinitrate for induction of cervical ripening: a randomised controlled trial to determine clinical efficacy and safety prior to first trimester surgical evacuation of retained products of conception.
Arteaga-Troncoso G; Villegas-Alvarado A; Belmont-Gomez A; Martinez-Herrera FJ; Villagrana-Zesati R; Guerra-Infante F
BJOG; 2005 Dec; 112(12):1615-9. PubMed ID: 16305563
[TBL] [Abstract][Full Text] [Related]
10. Cervical ripening with self administered iso sorbide mononitrate vaginally, in uncomplicated singleton pregnancies at 39 weeks gestation: a double blind randomised controlled trial.
Attanayake K; Goonewardene M
Ceylon Med J; 2016 Dec; 61(4):142-148. PubMed ID: 28076940
[TBL] [Abstract][Full Text] [Related]
11. Intravaginal administration of isosorbide mononitrate and misoprostol for cervical ripening and induction of labour: a randomized controlled trial.
Abdellah MS; Hussien M; Aboalhassan A
Arch Gynecol Obstet; 2011 Jul; 284(1):25-30. PubMed ID: 20582425
[TBL] [Abstract][Full Text] [Related]
12. Outpatient cervical ripening with nitric oxide donor isosorbide mononitrate prior to induction of labor.
Habib SM; Emam SS; Saber AS
Int J Gynaecol Obstet; 2008 Apr; 101(1):57-61. PubMed ID: 18222450
[TBL] [Abstract][Full Text] [Related]
13. Serum profile of isosorbide mononitrate after vaginal administration in the third trimester.
Bates CD; Nicoll AE; Mullen AB; Mackenzie F; Thomson AJ; Norman JE
BJOG; 2003 Jan; 110(1):64-7. PubMed ID: 12504938
[TBL] [Abstract][Full Text] [Related]
14. Outpatient cervical ripening before first-trimester surgical abortion: a comparison between misoprostol and isosorbide mononitrate.
Radulovic N; Norström A; Ekerhovd E
Acta Obstet Gynecol Scand; 2007; 86(3):344-8. PubMed ID: 17364311
[TBL] [Abstract][Full Text] [Related]
15. Outpatient cervical ripening by nitric oxide donors for prolonged pregnancy: a randomized controlled trial.
Schmitz T; Fuchs F; Closset E; Rozenberg P; Winer N; Perrotin F; Verspyck E; Azria E; Carbonne B; Lepercq J; Maillard F; Goffinet F;
Obstet Gynecol; 2014 Dec; 124(6):1089-1097. PubMed ID: 25415159
[TBL] [Abstract][Full Text] [Related]
16. Interruption of a study of cervical ripening with isosorbide mononitrate due to adverse effects.
Hatanaka AR; Moron AF; Auxiliadora de Aquino MM; de Souza E; de Silva Bussamra LC; Araujo Júnior E; Mattar R
Clin Exp Obstet Gynecol; 2012; 39(2):175-80. PubMed ID: 22905458
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of isosorbide mononitrate for cervical ripening prior to induction of labor for postdated pregnancy in an outpatient setting.
Agarwal K; Batra A; Batra A; Dabral A; Aggarwal A
Int J Gynaecol Obstet; 2012 Sep; 118(3):205-9. PubMed ID: 22721632
[TBL] [Abstract][Full Text] [Related]
18. The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term.
Osman I; MacKenzie F; Norrie J; Murray HM; Greer IA; Norman JE
Am J Obstet Gynecol; 2006 Apr; 194(4):1012-21. PubMed ID: 16580290
[TBL] [Abstract][Full Text] [Related]
19. Randomised trial of nitric oxide donor versus prostaglandin for cervical ripening before first-trimester termination of pregnancy.
Thomson AJ; Lunan CB; Ledingham M; Howat RC; Cameron IT; Greer IA; Norman JE
Lancet; 1998 Oct; 352(9134):1093-6. PubMed ID: 9798584
[TBL] [Abstract][Full Text] [Related]
20. Addition of vaginal isosorbide mononitrate for labor induction in pregnancies complicated by hypertensive diseases of pregnancy: a randomized controlled trial.
Gee SE; Ma'ayeh M; Cackovic H; Samuels P; Thung SF; Landon MB; Rood KM
Am J Obstet Gynecol MFM; 2021 Jul; 3(4):100343. PubMed ID: 33652160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]